Home
About
FAQ
History (2)
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?
Dihydropteridine Reductase
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?
Veverka KK, Feldman SR. Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat. 2018 Aug; 29(5):475-480.
View in:
PubMed
subject areas
Candidiasis, Chronic Mucocutaneous
Esophageal Neoplasms
Humans
Interleukin-17
Oropharyngeal Neoplasms
Prevalence
authors with profiles
Steven R. Feldman MD, PhD